| Literature DB >> 35859859 |
Vamshikrishna Reddy Sammeta1, John D Norris2, Sandeep Artham2, Chad D Torrice2, Jovita Byemerwa2, Carstyn Joiner3, Sean W Fanning3, Donald P McDonnell2, Timothy M Willson1.
Abstract
Despite continued interest in the development of nonsteroidal estrogens and antiestrogens, there are only a few chemotypes of estrogen receptor ligands. Using targeted screening in a ligand sensing assay, we identified a phenolic thieno[2,3-d]pyrimidine with affinity for estrogen receptor α. An efficient three-step synthesis of the heterocyclic core and structure-guided optimization of the substituents resulted in a series of potent nonsteroidal estrogens. The chemical tractability of the thieno[2,3-d]pyrimidine chemotype will support the design of new estrogen receptor ligands as therapeutic hormones and antihormones.Entities:
Year: 2022 PMID: 35859859 PMCID: PMC9290010 DOI: 10.1021/acsmedchemlett.2c00180
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.632